Table II.
Inhibitor
|
00-017 (S) | Cys-2,027-F1 (R)
|
Gly-2,078-F1 (R)
|
Ala-2,096-F1 (R)
|
|||
---|---|---|---|---|---|---|---|
I50 | I50 | R:S I50 Ratio | I50 | R:S I50 Ratio | I50 | R:S I50 Ratio | |
μm | μm | μm | μm | ||||
Cycloxydim (CHD) | 1.6 ± 0.1 | 7.8 ± 2.9 | 5.0 | 133.8 ± 6.7 | 83.5 | 14.7 ± 2.5 | 9.0 |
Clethodim (CHD) | 0.8 ± 0.2 | 2.2 ± 0.4 | 3.0 | 29.0 ± 4.6 | 36.0 | 5.2 ± 0.5 | 6.5 |
Fenoxaprop (APP) | 0.7 ± 0.2 | 37.0 ± 4.8 | 53.0 | 37.1 ± 3.7 | 53.0 | 14.3 ± 1.0 | 20.5 |
Clodinafop (APP) | 4.0 ± 1.1 | 361.8 ± 25.9 | 90.5 | 501.4 ± 50.7 | 125.5 | 230.1 ± 2.3 | 57.5 |
Haloxyfop (APP) | 1.4 ± 0.1 | 26.6 ± 3.0 | 19.0 | 48.7 ± 4.6 | 35.0 | 22.2 ± 0.1 | 16.0 |
Diclofop (APP) | 2.2 ± 0.5 | 46.9 ± 3.5 | 21.5 | 50.1 ± 2.3 | 23.0 | 21.8 ± 0.2 | 10.0 |